Biomarin Pharmaceutical Inc (BMRN)
Operating profit margin
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 615,495 | 776,080 | 619,645 | 484,214 | 337,026 | 253,658 | 198,772 | 172,714 | 133,995 | 101,053 | 74,639 | 149,562 | 108,182 | 57,380 | 29,900 | -82,341 | -61,301 | -64,023 | -116,640 | -36,765 |
| Revenue (ttm) | US$ in thousands | 3,094,001 | 3,063,608 | 2,950,227 | 2,853,915 | 2,752,809 | 2,588,398 | 2,471,644 | 2,419,226 | 2,310,557 | 2,234,572 | 2,173,095 | 2,096,039 | 2,008,311 | 1,911,709 | 1,879,604 | 1,846,275 | 1,848,588 | 1,916,630 | 1,844,422 | 1,860,435 |
| Operating profit margin | 19.89% | 25.33% | 21.00% | 16.97% | 12.24% | 9.80% | 8.04% | 7.14% | 5.80% | 4.52% | 3.43% | 7.14% | 5.39% | 3.00% | 1.59% | -4.46% | -3.32% | -3.34% | -6.32% | -1.98% |
September 30, 2025 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $615,495K ÷ $3,094,001K
= 19.89%
Peer comparison
Sep 30, 2025
Company name
Symbol
Operating profit margin
Biomarin Pharmaceutical Inc
BMRN
19.89%
Arrowhead Pharmaceuticals Inc
ARWR
11.86%
Regeneron Pharmaceuticals Inc
REGN
25.89%